A new controlled release system for standard 0.052″ and 0.038″ Gianturco coils
نویسندگان
چکیده
منابع مشابه
Embolization of a dural arteriovenous malformation using Gianturco coils.
A 16-year-old girl was seen by a local ophthalmolog ist because of diplopia and fullness of the right eye. Exam ination revealed visual acuity of 20/20 in both eyes with a 2-3 mm proptosis of the right eye. The right eye was also displaced downward with restri c tion of upward gaze and redness of the right canthus. There was a machineli ke bruit over the right eye and a thrill over the right su...
متن کاملPercutaneous closure of Blalock-Taussig shunts using Gianturco coils.
Permeability of a Blalock-Taussig shunt can increase the risk of endocarditis and ventricular overload. Percutaneous embolization of these shunts gives variable results. We report our experience in 10 patients with percutaneous closure of modified Blalock-Taussig shunts using retrograde arterial embolization with Gianturco coils. The patients' median age was 2.8 years, and their median weight w...
متن کاملTranscatheter occlusion of patent ductus arteriosus with Gianturco coils.
BACKGROUND Transcatheter occlusion with Gianturco coils has been attempted in a small number of patients with tiny (< or = 1.5-mm diameter) patent ductus arteriosus, and preliminary results have been encouraging. The present study extends this method to larger ductus sizes and makes recommendations for proper coil size selection. METHODS AND RESULTS Coil occlusion was attempted in 24 consecut...
متن کاملa new approach to credibility premium for zero-inflated poisson models for panel data
هدف اصلی از این تحقیق به دست آوردن و مقایسه حق بیمه باورمندی در مدل های شمارشی گزارش نشده برای داده های طولی می باشد. در این تحقیق حق بیمه های پبش گویی بر اساس توابع ضرر مربع خطا و نمایی محاسبه شده و با هم مقایسه می شود. تمایل به گرفتن پاداش و جایزه یکی از دلایل مهم برای گزارش ندادن تصادفات می باشد و افراد برای استفاده از تخفیف اغلب از گزارش تصادفات با هزینه پائین خودداری می کنند، در این تحقیق ...
15 صفحه اولPolymeric ocular nanosuspension for controlled release of acyclovir: in vitro release and ocular distribution
The aim of this study is to formulate a novel ophthalmic nanosuspension (ONS), an alternative carrier system to traditional colloidal carriers for controlled release (CR) of acyclovir (ACV). In the present study, ONS is employed to avoid some of major disadvantages of colloidal carriers systems such as instability in cul de sac and short half life by increasing efficiency of drug encapsulation ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 1998
ISSN: 0735-1097
DOI: 10.1016/s0735-1097(98)81310-7